InsideArbitrage Event Driven Monitor – June 9, 2026
Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage NUVL: The acquisition of Nuvalent, Inc. (NUVL) by GSK plc (GSK) for a…
Written byAsif SuriaSource: InsideArbitrage
Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage NUVL: The acquisition of Nuvalent, Inc. (NUVL) by GSK plc (GSK) for a closing value of $9.4 billion. GSK will commence a tender offer to acquire all of Nuvalent’s outstanding shares of Class A and Class